| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jan―17 |
Binding affinity between coronavirus spike protein and human ACE2 receptor |
Marcus Ho-Hin Shum, Yang Lee, Leighton Tam, Hui Xia, Oscar Lung-Wa Chung, Zhihong Guo, Tommy Tsan-Yuk Lam |
| 2 |
[GO] |
2024―Jan―09 |
Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19 |
Hythem Sidky, Kristen A. Hansen, Andrew T. Girvin, Nathan Hotaling, Sam G. Michael, Ken Gersing, David K. Sahner |
| 3 |
[GO] |
2023―Nov―10 |
Multi-omic analysis characterizes molecular susceptibility of receptors to SARS-CoV-2 spike protein |
Fanjie Wu, Chenghao Lin, Yutong Han, Dingli Zhou, Kang Chen, Minglei Yang, Qinyuan Xiao, Haiyue Zhang, Weizhong Li |
| 4 |
[GO] |
2023―Oct―17 |
Collaborative effects of 2019-nCoV-Spike mutants on viral infectivity |
Senbiao Fang, Chuqi Lei, Meng Li, Yongfan Ming, Liren Liu, Xuming Zhou, Min Li |
| 5 |
[GO] |
2023―Oct―17 |
Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity |
Boyu Pan, Senbiao Fang, Liangjiao Wang, Zhanyu Pan, Min Li, Liren Liu |
| 6 |
[GO] |
2023―Oct―01 |
Applying the digital data and the bioinformatics tools in SARS-CoV-2 research |
Meng Tan, Jiaxin Xia, Haitao Luo, Geng Meng, Zhenglin Zhu |
| 7 |
[GO] |
2023―Sep―28 |
Fast end-to-end surface interpretation of SARS-CoV-2 variants by differentiable molecular surface interaction fingerprinting method |
Ziyang Zheng, Yanqi Jiao, Haixin You, Junfeng An, Yao Sun |
| 8 |
[GO] |
2023―Sep―08 |
Corrigendum to “Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2″ [Computational and Structural Biotechnology Journal 19 (2021) 424-438] |
Abhinit Kumar, Saurabh Loharch, Sunil Kumar, Rajesh P. Ringe, Raman Parkesh |
| 9 |
[GO] |
2023―Sep―03 |
Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase |
Tiantian Xu, Lu Zhang |
| 10 |
[GO] |
2023―Jul―25 |
Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: implications for drug design |
Lena Mahmoudi Azar, Muhammed Miran Öncel, Elif Karaman, Levent Faruk Soysal, Ayesha Fatima, Sy Bing Choi, Alp Ertunga Eyupoglu, Batu Erman, Asif M. Khan, Serdar Uysal |
| 11 |
[GO] |
2023―Jul―25 |
Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro |
Zainab Jan, Anupriya M. Geethakumari, Kabir H. Biswas, Puthen Veettil Jithesh |
| 12 |
[GO] |
2023―Jun―12 |
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles |
Valentina Di Salvatore, Elena Crispino, Avisa Maleki, Giulia Nicotra, Giulia Russo, Francesco Pappalardo |
| 13 |
[GO] |
2023―May―25 |
Monomeric and dimeric states of human ZO1-PDZ2 are functional partners of the SARS-CoV-2 E protein |
Noah Giacon, Ettore Lo Cascio, Darcy S. Davidson, Marcelo D. Polêto, Justin A. Lemkul, Valeria Pennacchietti, Livia Pagano, Carlotta Zamparelli, Angelo Toto, Alessandro Arcovito |
| 14 |
[GO] |
2023―Mar―18 |
Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein |
M. Ghoula, S. Naceri, S. Sitruk, D. Flatters, G. Moroy, A.C. Camproux |
| 15 |
[GO] |
2023―Mar―12 |
Functional evolution of SARS-CoV-2 Spike protein: maintaining wide host spectrum and enhancing infectivity via surface charge of spike protein |
Xiaolong Lu, Yang Chen, Gong Zhang |
| 16 |
[GO] |
2023―Feb―11 |
In silico screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases |
Caio Felipe de Araujo Ribas Cheohen, Maria Eduarda Alves Esteves, Thamirys Silva da Fonseca, Carla Monteiro Leal, Fernanda de Lemos Fernandes Assis, Mariana Freire Campos, Raianne Soares Rebelo, Diego Allonso, Gilda Guimarães Leitão, Manuela Leal da Silva, Suzana Guimarães Leitão |
| 17 |
[GO] |
2023―Feb―09 |
Transcriptomics secondary analysis of severe human infection with SARS-CoV-2 identifies gene expression changes and predicts three transcriptional biomarkers in leukocytes |
Jeffrey Clancy, Curtis S. Hoffmann, Brett E. Pickett |
| 18 |
[GO] |
2023―Feb―08 |
Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein |
A. Vetráková, R. Kalianková Chovanová, R. Rechtoríková, D. Krajčíková, I. Barák |
| 19 |
[GO] |
2023―Jan―28 |
CoV2-TCR: a web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes |
Xingxing Jian, Yu Zhang, Jingjing Zhao, Zhuoming Zhao, Manman Lu, Lu Xie |
| 20 |
[GO] |
2023―Jan―19 |
SARS-CoV-2 and its impact on the cardiovascular and digestive systems - the interplay between new virus variants and human cells |
Angelika Szpulak, Urszula Garlak, Hanna Ćwirko, Bogusława Witkowska, Agnieszka Rombel-Bryzek, Danuta Witkowska |
| 21 |
[GO] |
2023―Jan―16 |
Valproate Coenzyme-A Conjugate Blocks Opening of Receptor Binding Domains in the Spike Trimer of SARS-CoV-2 through an Allosteric Mechanism |
Federica Maschietto, Tianyin Qiu, Jimin Wang, Yuanjun Shi, Brandon Allen, George P. Lisi, Elias Lolis, Victor S. Batista |
| 22 |
[GO] |
2022―Dec―09 |
SARS-CoV-2 virus classification based on stacked sparse autoencoder |
Maria G.F. Coutinho, Gabriel B.M. Câmara, Raquel M. Barbosa, Marcelo A.C. Fernandes |
| 23 |
[GO] |
2022―Nov―07 |
Structural and Energetic Analyses of SARS-CoV-2 N-Terminal Domain Characterise Sugar Binding Pockets and Suggest Putative Impacts of Variants on Covid-19 Transmission |
Su Datt Lam, Vaishali P. Waman, Franca Fraternali, Christine Orengo, Jonathan Lees |
| 24 |
[GO] |
2022―Nov―04 |
Landscape of infection enhancing antibodies in COVID-19 and healthy donors |
Hendra S. Ismanto, Zichang Xu, Dianita S. Saputri, Jan Wilamowski, Songling Li, Dendi K. Nugraha, Yasuhiko Horiguchi, Masato Okada, Hisashi Arase, Daron M Standley |
| 25 |
[GO] |
2022―Nov―03 |
Computational analysis of interior mutations of SARS-CoV-2 Spike protein suggest a balance of protein stability and S2: S1 separation propensity |
Zhen-lu Li, Matthias Buck |
| 26 |
[GO] |
2022―Nov―02 |
Fever temperatures modulate intraprotein dynamics and enhance the binding affinity between monoclonal antibodies and the Spike protein from SARS-CoV-2 |
Dong Gun Kim, Hak Sung Kim, Yoonjoo Choi, Razvan C. Stan |
| 27 |
[GO] |
2022―Oct―28 |
On the intrinsic nature of viral pathogenesis: the assumption of a Darwinian paradigm to describe COVID-19 pandemic |
Pier Francesco Roggero, Arianna Calistri, Giorgio Palé |
| 28 |
[GO] |
2022―Oct―27 |
MOLECULAR MIMICRY OF SARS-COV-2 SPIKE PROTEIN IN THE NERVOUS SYSTEM: A BIOINFORMATICS APPROACH |
Andres Felipe Cuspoca, Pablo Isaac Estrada, Alberto Velez-van-Meerbeke |
| 29 |
[GO] |
2022―Oct―17 |
Recent computational drug repositioning strategies against SARS-CoV-2 |
Lu Lu, Jiale Qin, Jiandong Chen, Na Yu, Satoru Miyano, Zhenzhong Deng, Chen Li |
| 30 |
[GO] |
2022―Sep―08 |
Subtle structural differences of nucleotide analogs may impact SARS-CoV-2 RNA-dependent RNA polymerase and exoribonuclease activity |
Abraham Madariaga-Mazón, José J. Naveja, Arturo Becerra, José Alberto Campillo-Balderas, Ricardo Hernández-Morales, Rodrigo Jácome, Antonio Lazcano, Karina Martinez-Mayorga |
| 31 |
[GO] |
2022―Sep―07 |
Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2 |
Yao Sun, Yanqi Jiao, Chengcheng Shi, Yang Zhang |
| 32 |
[GO] |
2022―Aug―30 |
A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis |
Xiaolong Feng, Xiaofan Zhang, Shuangying Jiang, Yuanwei Tang, Chao Cheng, Parthasarathy Abinand Krishna, Xiaoting Wang, Junbiao Dai, Dan Zhao, Tian Xia, Jianyang Zeng |
| 33 |
[GO] |
2022―Aug―13 |
Synthetically recoded virus sCPD9 - a tool to accelerate SARS-CoV-2 research under biosafety level 2 conditions |
Dusan Kunec, Nikolaus Osterrieder, Jakob Trimpert |
| 34 |
[GO] |
2022―Aug―10 |
Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: screening of targets and understanding pathogenesis |
Abdul Arif Khan, Sudhir K. Jain, Mahendra Rai, Samiran Panda |
| 35 |
[GO] |
2022―Aug―08 |
Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection |
Herdiantri Sufriyana, Hotimah Masdan Salim, Akbar Reza Muhammad, Yu-Wei Wu, Emily Chia-Yu Su |
| 36 |
[GO] |
2022―Aug―08 |
Evaluation of the role of vaccination in the COVID-19 pandemic based on the data from the 50 U.S. States |
Rongfang Nie, Zeinab Abdelrahman, Zhixian Liu, Xiaosheng Wang |
| 37 |
[GO] |
2022―Aug―08 |
Evaluation of Immune Evasion in SARS-CoV-2 Delta and Omicron variants |
Armi M. Chaudhari, Madhvi Joshi, Dinesh Kumar, Amrutlal Patel, Kiran Bharat Lokhande, Anandi Krishnan, Katja Hanack, Slawomir Filipek, Dorian Liepmann, Venkatesan Renugopalakrishnan, Ramasamy Paulmurugan, Chaitanya Joshi |
| 38 |
[GO] |
2022―Aug―05 |
Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2 |
Ruba Al Khalaf, Anna Bernasconi, Pietro Pinoli, Stefano Ceri |
| 39 |
[GO] |
2022―Jul―30 |
Path to normality: Assessing the level of social-distancing measures relaxation against antibody-resistant SARS-CoV-2 variants in a partially-vaccinated population |
Jing-Bo Liang, Hsiang-Yu Yuan, Kin-Kit Li, Wan In Wei, Samuel Yeung Shan Wong, Arthur Tang, Steven Riley, Kin On Kwok |
| 40 |
[GO] |
2022―Jul―28 |
Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages |
Hang-Yu Zhou, Ye-Xiao Cheng, Lin Xu, Jia-Ying Li, Chen-Yue Tao, Cheng-Yang Ji, Na Han, Rong Yang, Hui Wu, Yaling Li, Aiping Wu |
| 41 |
[GO] |
2022―Jul―20 |
Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication |
Ines Thiele, Ronan M.T. Fleming |
| 42 |
[GO] |
2022―Jul―02 |
Tracing the cell-type-specific modules of immune responses during COVID-19 progression using scDisProcema |
Anyao Li, Jihong Yang, Jingyang Qian, Xin Shao, Jie Liao, Xiaoyan Lu, Xiaohui Fan |
| 43 |
[GO] |
2022―Jun―23 |
Severe Acute Respiratory Syndrome Coronavirus 2 Variants-Possibility of Universal Vaccine Design: A Review |
Eunhye Yoon, Dahyun Kim, Hyeeun Jeon, Yejin Kwon, Yejin Jang, Sulhee Kim, Kwang Yeon Hwang |
| 44 |
[GO] |
2022―Jun―14 |
Maturation of the SARS-CoV-2 virus is regulated by dimerization of its main protease |
Shreyas Kaptan, Mykhailo Girych, Giray Enkavi, Waldemar Kulig, Vivek Sharma, Joni Vuorio, Tomasz Rog, Ilpo Vattulainen |
| 45 |
[GO] |
2022―Jun―03 |
Data-driven platform for identifying variants of interest in COVID-19 virus |
Priya Ramarao-Milne, Yatish Jain, Letitia M.F. Sng, Brendan Hosking, Carol Lee, Arash Bayat, Michael Kuiper, Laurence O.W. Wilson, Natalie A. Twine, Denis C. Bauer |
| 46 |
[GO] |
2022―May―30 |
Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies |
Bodee Nutho, Patcharin Wilasluck, Peerapon Deetanya, Kittikhun Wangkanont, Patcharee Arsakhant, Rungnapha Saeeng, Thanyada Rungrotmongkol |
| 47 |
[GO] |
2022―May―27 |
Beyond COVID-19 Pandemic: Topology-aware optimization of vaccination strategy for minimizing virus spreading |
Francesco Petrizzelli, Pietro Hiram Guzzi, Tommaso Mazza |
| 48 |
[GO] |
2022―May―19 |
Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking |
Sara Donzelli, Ludovica Ciuffreda, Martina Pontone, Martina Betti, Alice Massacci, Carla Mottini, Francesca De Nicola, Giulia Orlandi, Frauke Goeman, Eugenia Giuliani, Eleonora Sperandio, Giulia Piaggio |
| 49 |
[GO] |
2022―May―17 |
Potential Drug Discovery for COVID-19 Treatment Targeting Cathepsin L Using a Deep Learning-Based Strategy |
Wei-Li Yang, Qi Li, Jing Sun, Sia Huat Tan, Yan-Hong Tang, Miao-Miao Zhao, Yu-Yang Li, Xi Cao, Jin-Cun Zhao, Jin-Kui Yang |
| 50 |
[GO] |
2022―May―10 |
Reconstruction of the Origin of the First Major SARS-CoV-2 Outbreak in Germany |
Marek Korencak, Sugirthan Sivalingam, Anshupa Sahu, Dietmar Dressen, Axel Schmidt, Fabian Brand, Peter Krawitz, Libor Hart, Anna Maria Eis-Hübinger, Andreas Buness, Hendrik Streeck |
| 51 |
[GO] |
2022―May―02 |
Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies |
Daria Beshnova, Yan Fang, Mingjian Du, Yehui Sun, Fenghe Du, Jianfeng Ye, Zhijian James Chen, Bo Li |
| 52 |
[GO] |
2022―Apr―26 |
SARS-CoV-2 Pan-variant Inhibitory Peptides Deter S1-ACE2 Interaction and Neutralize Delta and Omicron Pseudoviruses |
Masaud Shah, Sung Ung Moon, Jang Hyun Kim, Trinh Thanh Thao, Hyun Goo Woo |
| 53 |
[GO] |
2022―Apr―21 |
SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants |
Hoyin Chung, Ji Yeong Noh, Bon-Sang Koo, Jung Joo Hong, Hye Kwon Kim |
| 54 |
[GO] |
2022―Apr―09 |
Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to covid-19 |
Harry Ridgway, Graham J. Moore, Thomas Mavromoustakos, Sotiris Tsiodras, Irene Ligielli, Konstantinos Kelaidonis, Christos T. Chasapis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Russell Petty, Ioannis Karakasiliotis, Vassilis G. Gorgoulis, John M. Matsoukas |
| 55 |
[GO] |
2022―Mar―18 |
Both Simulation and Sequencing Data Reveal Coinfections with Multiple SARS-CoV-2 Variants in the COVID-19 Pandemic |
Yinhu Li, Yiqi Jiang, Zhengtu Li, Yonghan Yu, Jiaxing Chen, Wenlong Jia, Yen Kaow Ng, Feng Ye, Shuai Cheng Li, Bairong Shen |
| 56 |
[GO] |
2022―Mar―14 |
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds |
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, Paul Christakopoulos |
| 57 |
[GO] |
2022―Feb―26 |
Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike - ACE2 complexes reveal distinct changes between both variants |
Eileen Socher, Lukas Heger, Friedrich Paulsen, Friederike Zunke, Philipp Arnold |
| 58 |
[GO] |
2022―Feb―24 |
COVID-19 infection and neurodegeneration: Computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes |
Lucija Hok, Hrvoje Rimac, Janez Mavri, Robert Vianello |
| 59 |
[GO] |
2022―Feb―04 |
Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: From in silico screening to experimentally validated inhibitory activity |
Tanaporn Uengwetwanit, Nopporn Chutiwitoonchai, Kanin Wichapong, Nitsara Karoonuthaisiri |
| 60 |
[GO] |
2022―Jan―31 |
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants |
Jialing Yin, Chengcheng Li, Chunhong Ye, Zhihui Ruan, Yicong Liang, Yongkui Li, Jianguo Wu, Zhen Luo |
| 61 |
[GO] |
2022―Jan―31 |
D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1 |
Suchetana Gupta, Ditipriya Mallick, Kumarjeet Banerjee, Shrimon Mukherjee, Soumyadev Sarkar, Sonny TM Lee, Partha Basuchowdhuri, Siddhartha S Jana |
| 62 |
[GO] |
2022―Jan―31 |
Evaluation of protein descriptors in computer-aided rational protein engineering tasks and its application in property prediction in SARS-CoV-2 spike glycoprotein |
Hocheol Lim, Hyeon-Nae Jeon, Seungcheol Lim, Yuil Jang, Taehee Kim, Hyein Cho, Jae-Gu Pan, Kyoung Tai No |
| 63 |
[GO] |
2022―Jan―29 |
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing |
Max Luedemann, Daniela Stadler, Cho-Chin Cheng, Ulrike Protzer, Percy A. Knolle, Sainitin Donakonda |
| 64 |
[GO] |
2022―Jan―21 |
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects |
Sara Donzelli, Francesca Spinella, Enea Gino di Domenico, Martina Pontone, Ilaria Cavallo, Giulia Orlandi, Stefania Iannazzo, Giulio Maria Ricciuto, ISG Virology Covid Team, Raul Pellini, Paola Muti, Sabrina Strano, Gennaro Ciliberto, Fabrizio Ensoli, Stefano Zapperi, Caterina A.M. La Porta, Giovanni Blandino, Aldo Morrone, Fulvia Pimpinelli |
| 65 |
[GO] |
2022―Jan―11 |
Probing the Formation, Structure and Free Energy Relationships of M Protein Dimers of SARS-CoV-2 |
Yipeng Cao, Rui Yang, Wei Wang, Shengpeng Jiang, Chengwen Yang, Ningbo Liu, Hongji Dai, Imshik Lee, Xiangfei Meng, Zhiyong Yuan |
| 66 |
[GO] |
2021―Dec―11 |
The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour |
A. Sofia F. Oliveira, Deborah K. Shoemark, Amaurys Avila Ibarra, Andrew D. Davidson, Imre Berger, Christiane Schaffitzel, Adrian J. Mulholland |
| 67 |
[GO] |
2021―Dec―05 |
Pandemic Strategies with Computational and Structural Biology against COVID-19: A Retrospective |
Ching-Hsuan Liu, Cheng-Hua Lu, Liang-Tzung Lin |
| 68 |
[GO] |
2021―Nov―25 |
Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 Mpro and its evolutionary mutations as a case study |
Olivier Sheik Amamuddy, Rita Afriyie Boateng, Victor Barozi, Dorothy Wavinya Nyamai, Özlem Tastan Bishop |
| 69 |
[GO] |
2021―Nov―20 |
Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods |
Li Gao, Guo-Sheng Li, Jian-Di Li, Juan He, Yu Zhang, Hua-Fu Zhou, Jin-Liang Kong, Gang Chen |
| 70 |
[GO] |
2021―Nov―08 |
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon |
Jordi Mayneris-Perxachs, José-Maria Moreno-Navarrete, Marta Ballanti, Giovanni Monteleone, Omero Alessandro Paoluzi, Geltrude Mingrone, Philippe Lefebvre, Bart Staels, Massimo Federici, Josep Puig, Josep Garre, Rafael Ramos, José Manuel Fernández-Real |
| 71 |
[GO] |
2021―Nov―03 |
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells |
Barbara Storti, Paola Quaranta, Cristina Di Primio, Nicola Clementi, Nicasio Mancini, Elena Criscuolo, Pietro Giorgio Speziax, Vittoria Carnicelli, Giulia Lottini, Emanuele Paolini, Giulia Freer, Michele Lai, Mario Costa, Fabio Beltram, Alberto Diaspro, Mauro Pistello, Riccardo Zucchi, Paolo Bianchini, Giovanni Signore, Ranieri Bizzarri |
| 72 |
[GO] |
2021―Oct―09 |
In silico antibody engineering for SARS-CoV-2 detection |
Didac Martí, Eduard Martín-Martínez, Juan Torras, Oscar Bertran, Pau Turon, Carlos Alemán |
| 73 |
[GO] |
2021―Oct―05 |
N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains |
Apostolos Klinakis, Zoe Cournia, Theodoros Rampias |
| 74 |
[GO] |
2021―Sep―20 |
Polyphenols as Alternative Treatments of COVID-19 |
Yifei Wu, Scott D. Pegan, David Crich, Ellison Desrochers, Edward B. Starling, Madelyn C. Hansen, Carson Booth, Lauren Nicole Mullininx, Lei Lou, Kuan Y. Chang, Zhong-Ru Xie |
| 75 |
[GO] |
2021―Sep―03 |
Computational Insights into the Membrane Fusion Mechanism of SARS-CoV-2 at the Cellular Level |
Jimin Wang, Federica Maschietto, Matthew J. Guberman-Pfeffer, Krystle Reiss, Brandon Allen, Yong Xiong, Elias Lolis, Victor S. Batista |
| 76 |
[GO] |
2021―Sep―02 |
Predicted pH-dependent stability of SARS-CoV-2 spike protein trimer from interfacial acidic groups |
Vanessa R. Lobo, Jim Warwicker |
| 77 |
[GO] |
2021―Sep―01 |
Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: a systematic review |
Jingxuan Wang, Xiao Chen, Zihao Guo, Shi Zhao, Ziyue Huang, Zian Zhuang, Eliza Lai-yi Wong, Benny Chung-Ying Zee, Marc Ka Chun Chong, Maggie Haitian Wang, Eng Kiong Yeoh |
| 78 |
[GO] |
2021―Sep―01 |
Rapid reconstruction of porcine reproductive and respiratory syndrome virus using synthetic DNA fragments |
Julien Mélade, Géraldine Piorkowski, Hawa Sophia Bouzidi, Alain Medawar, Claudine Raffy, Xavier de Lamballerie, Antoine Nougairède |
| 79 |
[GO] |
2021―Aug―24 |
An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2 |
Fangfang Yan, Feng Gao |
| 80 |
[GO] |
2021―Aug―19 |
Docking-Generated Multiple Ligand Poses for Bootstrapping Bioactivity Classifying Machine Learning: Repurposing Covalent Inhibitors for COVID-19-Related TMPRSS2 as Case Study |
Ma'mon M. Hatmal, Omar Abuyman, Mutasem Taha |
| 81 |
[GO] |
2021―Aug―12 |
Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2 |
Ponciano García-Gutiérrez, Rafael A. Zubillaga, Ilich A. Ibarra, Ana Martínez, Rubicelia Vargas, Jorge Garza |
| 82 |
[GO] |
2021―Jul―26 |
Immune evasion of SARS-CoV-2 from interferon antiviral system |
Yuan-Qin Min, Mengzhuo Huang, Xiulian Sun, Fei Deng, Hualin Wang, Yun-Jia Ning |
| 83 |
[GO] |
2021―Jul―26 |
Binding Affinity and Mechanisms of SARS-CoV-2 Variants |
Yanqiang Han, Zhilong Wang, Zhiyun Wei, Igor Schapiro, Jinjin Li |
| 84 |
[GO] |
2021―Jul―10 |
Exploiting the Molecular Basis of Age and Gender Differences in Outcomes of SARS-CoV-2 Infections. |
Daniele Mercatelli, Elisabetta Pedace, Pierangelo Veltri, Federico M. Giorgi, Pietro Hiram Guzzi |
| 85 |
[GO] |
2021―Jul―02 |
Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses |
Christopher A. Beaudoin, Arian R Jamasb, Ali F. Alsulami, Liviu Copoiu, Andries J. van Tonder, Sharif Hala, Bridget P. Bannerman, Sherine E. Thomas, Sundeep Chaitanya Vedithi, Pedro H.M. Torres, Tom L. Blundell |
| 86 |
[GO] |
2021―Jun―29 |
Cardiovascular, Cerebrovascular, and Renal Co-morbidities in COVID-19 Patients: A Systematic-Review and Meta-analysis |
Abby C. Lee, Wei Tse Li, Lauren Apostol, Jiayan Ma, Pam R. Taub, Eric Y. Chang, Mahadevan Rajasekaran, Weg M. Ongkeko |
| 87 |
[GO] |
2021―Jun―24 |
Evolution, Correlation, Structural Impact and Dynamics of Emerging SARS-CoV-2 Variants |
Austin N. Spratt, Saathvik R. Kannan, Lucas T. Woods, Gary A. Weisman, Thomas P. Quinn, Christian L. Lorson, Anders Sönnerborg, Siddappa N. Byrareddy, Kamal Singh |
| 88 |
[GO] |
2021―Jun―17 |
Eleven Routine Clinical Features Predict COVID-19 Severity Uncovered by Machine Learning of Longitudinal Measurements |
Kai Zhou, Yaoting Sun, Lu Li, Zelin Zang, Jing Wang, Jun Li, Junbo Liang, Fangfei Zhang, Qiushi Zhang, Weigang Ge, Hao Chen, Xindong Sun, Liang Yue, Xiaomai Wu, Bo Shen, Jiaqin Xu, Hongguo Zhu, Shiyong Chen, Hai Yang, Shigao Huang, Minfei Peng, Dongqing Lv, Chao Zhang, Haihong Zhao, Luxiao Hong, Zhehan Zhou, Haixiao Chen, Xuejun Dong, Chunyu Tu, Minghui Li, Yi Zhu, Baofu Chen, Stan Z. Li, Tiannan Guo |
| 89 |
[GO] |
2021―Jun―14 |
Temperature responsive smart polymer for enabling affinity enrichment of current coronavirus (SARS-CoV-2) to improve its diagnostic sensitivity |
Ahmed Nabil, Erika Yoshihara, Keita Hironaka, Ayman A. Hassan, Gamal Shiha, Mitsuhiro Ebara |
| 90 |
[GO] |
2021―Jun―05 |
Interaction of 8-Anilinonaphthalene-1-Sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification |
Peerapon Deetanya, Kowit Hengphasatporn, Patcharin Wilasluck, Yasuteru Shigeta, Thanyada Rungrotmongkol, Kittikhun Wangkanont |
| 91 |
[GO] |
2021―Jun―05 |
The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival |
L. Ponoop Prasad Patro, Chakkarai Sathyaseelan, Patil Pranita Uttamrao, Thenmalarchelvi Rathinavelan |
| 92 |
[GO] |
2021―May―26 |
Screening of World Approved Drugs against Highly Dynamical Spike Glycoprotein of SARS-CoV-2 using CaverDock and Machine Learning |
Gaspar P. Pinto, Ondrej Vavra, Sergio M. Marques, Jiri Filipovic, David Bednar, Jiri Damborsky |
| 93 |
[GO] |
2021―May―24 |
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning |
Akanksha Rajput, Anamika Thakur, Adhip Mukhopadhyay, Sakshi Kamboj, Amber Rastogi, Sakshi Gautam, Harvinder Jassal, Manoj Kumar |
| 94 |
[GO] |
2021―May―13 |
Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition. |
Lorenzo Di Rienzo, Michele Monti, Edoardo Milanetti, Mattia Miotto, Alberto Boffi, Gian Gaetano Tartaglia, Giancarlo Ruocco |
| 95 |
[GO] |
2021―May―07 |
Artificial Intelligence in clinical care amidst COVID-19 Pandemic: A Systematic Review |
Eleni S. Adamidi, Konstantinos Mitsis, Konstantina S. Nikita |
| 96 |
[GO] |
2021―May―04 |
Evidence of a Putative Glycosaminoglycan Binding Site on the Glycosylated SARS-CoV-2 Spike Protein N-terminal domain |
Zachariah P. Schuurs, Edward Hammond, Stefano Elli, Timothy R. Rudd, Courtney J. Mycroft-West, Marcelo A. Lima, Mark A. Skidmore, Richard Karlsson, Yen-Hsi Chen, Ieva Bagdonaite, Zhang Yang, Yassir A Ahmed, Derek J. Richard, Jeremy Turnbul, Vito Ferro, Deirdre R. Coombe, Neha S. Gandhi |
| 97 |
[GO] |
2021―Apr―30 |
Clinical evaluation of SARS-CoV-2 Lung HRCT and RT-PCR Techniques: Towards risk factor based diagnosis of infectious diseases |
Fariba Asadi, Razieh Shahnazari, Nikhil Bhalla, Amir Farokh Payam |
| 98 |
[GO] |
2021―Apr―27 |
Laboratory indicators in COVID-19 and other pneumonias: Analysis for differential diagnosis and comparison of dynamic changes during 400-day follow-up |
Jing Wang, Yufen Zheng, Yijun Chen, Xingzhong Hu, Minfei Peng, Yicheng Fang, Bo Shen, Guoguang Lu |
| 99 |
[GO] |
2021―Apr―27 |
An overview of current COVID-19 vaccine platforms |
Abdou Nagy, Bader Alhatlani |
| 100 |
[GO] |
2021―Apr―26 |
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: lessons from the pandemic and preparing for future health crises |
Natesh Singh, Bruno O. Villoutreix |
| 101 |
[GO] |
2021―Apr―23 |
Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis |
Zeinab Abdelrahman, Zuobing Chen, Haoyu Lyu, Xiaosheng Wang |
| 102 |
[GO] |
2021―Apr―16 |
Targeting protein-protein interaction interfaces in COVID-19 drug discovery |
Chung-ke Chang, Shan-Meng Lin, Roshan Satange, Shih-Chao Lin, Sin-Cih Sun, Hung-Yi Wu, Kylene Kehn-Hall, Ming-Hon Hou |
| 103 |
[GO] |
2021―Apr―08 |
Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification |
Xiaowei Li, Wenhua Zhu, Meiyang Fan, Jing Zhang, Yizhao Peng, Fumeng Huang, Nan Wang, Langchong He, Lei Zhang, Rikard Holmdahl, Liesu Meng, Shemin Lu |
| 104 |
[GO] |
2021―Apr―07 |
Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity |
Sugandh Kumar, Bharati Singh, Pratima Kumari, Preethy V. Kumar, Geetanjali Agnihotri, Shaheerah Khan, Tushar Kant Beuria, Gulam Hussain Syed, Anshuman Dixit |
| 105 |
[GO] |
2021―Apr―07 |
Temperature effect on the SARS-CoV-2: A Molecular dynamics study of the spike homotrimeric glycoprotein |
Didac Martí, Juan Torras, Oscar Bertran, Pau Turon, Carlos Alemán |
| 106 |
[GO] |
2021―Apr―06 |
Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process |
Hong Zheng, Shengwei Jin, Ting Li, Weiyang Ying, Binyu Ying, Dong Chen, Jie Ning, Chanfan Zheng, Yuping Li, Chen Li, Chengshui Chen, Xiaokun Li, Hongchang Gao |
| 107 |
[GO] |
2021―Apr―05 |
AutoVEM: an automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution |
Binbin Xi, Dawei Jiang, Shuhua Li, Jerome R Lon, Yunmeng Bai, Shudai Lin, Meiling Hu, Yuhuan Meng, Yimo Qu, Yuting Huang, Wei Liu, Lizhen Huang, Hongli Du |
| 108 |
[GO] |
2021―Mar―27 |
Neuropilins: C-end rule peptides and their association with nociception and COVID-19 |
Amie Jobe, Ranjit Vijayan |
| 109 |
[GO] |
2021―Mar―27 |
Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 Infectivity |
Sally Esmail, Wayne R Danter |
| 110 |
[GO] |
2021―Mar―23 |
A model to predict the risk of mortality in severely ill COVID-19 patients |
Bo Chen, Hongqiu Gu, Yi Liu, Guqin Zhang, Hang Yang, Huifang Hu, Chenyang Lu, Yang Li, Liyi Wang, Yi Liu, Yi Zhao, Huaqin Pan |
| 111 |
[GO] |
2021―Mar―23 |
SARS-CoV-2 Infection and Smoking: What is the association? A brief review |
Ishita Gupta, Muhammad Umar Sohail, Khaled E. Elzawawi, Ahmed H. Amarah, Semir Vranic, Maha Al-Asmakh, Ala-Eddin Al Moustafa |
| 112 |
[GO] |
2021―Mar―23 |
Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: implications for advanced antibody design |
Daojiong Wang, Yushu Ge, Bin Zhong, Dan Liu |
| 113 |
[GO] |
2021―Mar―19 |
Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins |
Ettore Lo Cascio, Angelo Toto, Gabriele Babini, Flavio De Maio, Maurizio Sanguinetti, Alvaro Mordente, Stefano Della Longa, Alessandro Arcovito |
| 114 |
[GO] |
2021―Mar―02 |
The Conundrum of Giglio Island: unraveling the dynamics of an apparent resistance to COVID-19 - A descriptive study |
Antonio Bognanni, Armando Schiaffino, Fulvia Pimpinelli, Sara Donzelli, Ilaria Celesti, Sabrina Strano, Elena Solari, Giorgia Schiaffino, Gabriele Solari, Domenico Solari, Serena Delbue, Marta Rigoni, Giandomenico Nollo, Greta E. Muti, Giovanna E.U. Muti Schünemann, Holger J Schünemann, Giovanni Blandino, Aldo Morrone, Paola Muti |
| 115 |
[GO] |
2021―Mar―02 |
Deep learning for COVID-19 chest CT (computed tomography) image analysis: a lesson from lung cancer |
Hao Jiang, Shiming Tang, Weihuang Liu, Yang Zhang |
| 116 |
[GO] |
2021―Mar―02 |
COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection? |
Mohammed S. Razzaque |
| 117 |
[GO] |
2021―Feb―27 |
Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
Adrián Palacios Chavarria, Rafael Ricardo Valdez Vázquez, José Guillermo Domínguez Cherit, Héctor Herrera Bello, Humberto Castillejos Suastegui, Lidia Moreno-Castañeda, Gabriela Alanís Estrada, Fabián Hernández, Omar González-Marcos, Huitzilihuitl Saucedo-Orozco, Linaloe Manzano Pech, Ricardo Márquez, Verónica Guarner-Lans, Israel Pérez Torres, Maria Elena Soto |
| 118 |
[GO] |
2021―Feb―21 |
Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: the case of Spike protein of SARS-CoV-2 virus |
Wai-Yim Ching, Puja Adhikari, Bahaa Jawad, Rudolf Podgornik |
| 119 |
[GO] |
2021―Feb―09 |
3044 cases reveal important prognosis signatures of COVID-19 patients |
Shijie Qin, Weiwei Li, Xuejia Shi, Yanjun Wu, Canbiao Wang, Jiawei Shen, Rongrong Pang, Bangshun He, Jun Zhao, Qinghua Qiao, Tao Luo, Yanju Guo, Yang Yang, Ying Han, Qiuyue Wu, Jian Wu, Wei Dai, Libo Zhang, Liming Chen, Chunyan Xue, Ping Jin, Zhenhua Gan, Fei Ma, Xinyi Xia |
| 120 |
[GO] |
2021―Jan―30 |
The Paradoxical Problem with COVID-19 Ocular Infection: Moderate Clinical Manifestation and Potential Infection Risk |
Jiawei Shen, Jian Wu, Yang Yang, Pengcheng Wang, Tao Luo, Yanju Guo, Jun Zhao, Wei Dai, Ying Han, Peiran Zhu, Qiuyue Wu, Weiwei Li, Andrew Chen, Chunyan Xue, Xinyi Xia |
| 121 |
[GO] |
2021―Jan―30 |
Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP |
Yeu-Yang Tseng, Guan-Ru Liao, Abigail Lien, Wei-Li Hsu |
| 122 |
[GO] |
2021―Jan―27 |
Chemokines and chemokine receptors during COVID-19 infection |
Bariaa A. Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi |
| 123 |
[GO] |
2021―Jan―14 |
Managing children with brain tumors during the COVID-19 era: don’t stop the care! |
Michele Antonio Capozza, Silvia Triarico, Giorgio Attinà, Alberto Romano, Stefano Mastrangelo, Palma Maurizi, Paolo Frassanito, Federico Bianchi, Tommaso Verdolotti, Marco Gessi, Mario Balducci, Luca Massimi, Gianpiero Tamburrini, Antonio Ruggiero |
| 124 |
[GO] |
2021―Jan―14 |
Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs |
Camila Pontes, Victoria Ruiz-Serra, Rosalba Lepore, Alfonso Valencia |
| 125 |
[GO] |
2020―Dec―31 |
Novel coronavirus disease (COVID-19) pandemic: A recent mini review |
Muhammad Fayyaz ur Rehman, Chaudhary Fariha, Aqsa Anwar, Naveed Shahzad, Munir Ahmad, Salma Mukhtar, Muhammad Farhan Ul Haque |
| 126 |
[GO] |
2020―Dec―31 |
Computational Design of SARS-CoV-2 Spike Glycoproteins to Increase Immunogenicity by T Cell Epitope Engineering |
Edison Ong, Xiaoqiang Huang, Robin Pearce, Yang Zhang, Yongqun He |
| 127 |
[GO] |
2020―Dec―29 |
Computational modelling supports that Dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity? |
Himadri Nath, Abinash Mallick, Subrata Roy, Soumi Sukla, Subhajit Biswas |
| 128 |
[GO] |
2020―Dec―29 |
Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2 |
Abhinit Kumar, Saurabh Loharch, Sunil Kumar, Rajesh P Ringe, Raman Parkesh |
| 129 |
[GO] |
2020―Dec―28 |
Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2 |
Haixia Zhu, Wenhao Du, Menghua Song, Qing Liu, Andreas Herrmann, Qiang Huang |
| 130 |
[GO] |
2020―Dec―25 |
Meta-analysis of Transcriptome Datasets: an Alternative Method to Study IL-6 Regulation in Coronavirus Disease 2019 |
Hui Liu, Shujin Lin, Xiulan Ao, Xiangwen Gong, Chunyun Liu, Dechang Xu, Yumei Huang, Zhiqiang Liu, Bixing Zhao, Xiaolong Liu, Xiao Han, Hanhui Ye |
| 131 |
[GO] |
2020―Dec―18 |
Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes |
Ruchi Jain, Sathishkumar Ramaswamy, Divinlal Harilal, Mohammed Uddin, Tom Loney, Norbert Nowotny, Hanan Alsuwaidi, Rupa Varghese, Zulfa Deesi, Abdulmajeed Alkhajeh, Hamda Khansaheb, Alawi Alsheikh-Ali, Ahmad Abou Tayoun |
| 132 |
[GO] |
2020―Dec―17 |
Temperature Dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome |
Zhonghua Zhou, Ziyi Yang, Junxian Ou, Hong Zhang, Qiwei Zhang, Ming Dong, Gong Zhang |
| 133 |
[GO] |
2020―Dec―06 |
Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses |
Guobing Li, Xiaolu Zhao, Qi Liu, Shasha Ruan, Yali Dou, Fengbiao Mao |
| 134 |
[GO] |
2020―Dec―06 |
L1000 Connectivity Map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies |
Wezi Sendama |
| 135 |
[GO] |
2020―Dec―04 |
A recent origin of Orf3a from M protein across the coronavirus lineage arising by sharp divergence |
Christos A. Ouzounis |
| 136 |
[GO] |
2020―Nov―29 |
ACE2 partially dictates the host range and tropism of SARS-CoV-2 |
Shan Gao, Leiliang Zhang |
| 137 |
[GO] |
2020―Nov―20 |
Utilizing microbiome approaches to assist source tracking, treatment and prevention of COVID-19: Review and Assessment |
Maozhen Han, Yuguo Zha, Hui Chong, Chaofang Zhong, Kang Ning |
| 138 |
[GO] |
2020―Nov―20 |
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2 |
Desh Deepak Singh, Ihn Han, Eun-Ha Choi, Dharmendra Kumar Yadav |
| 139 |
[GO] |
2020―Nov―20 |
SARS-CoV2 infectivity is potentially modulated by host redox status |
Jaswinder Singh, Rajinder S. Dhindsa, Vikram Misra, Baljit Singh |
| 140 |
[GO] |
2020―Nov―12 |
Mutations in the SARS-CoV-2 Spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization |
Masaud Shah, Bilal Ahmad, Sangdun Choi, Hyun Goo Woo |
| 141 |
[GO] |
2020―Nov―11 |
In silico and In vitro Studies Reveal Complement System Drives Coagulation Cascade in SARS-CoV-2 Pathogenesis |
Ritudhwaj Tiwari, Anurag R. Mishra, Flora Mikaeloff, Soham Gupta, Ali Mirazimi, Siddappa N. Byrareddy, Ujjwal Neogi, Debasis Nayak |
| 142 |
[GO] |
2020―Nov―11 |
Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor |
Boyu Pan, Senbiao Fang, Ju Zhang, Ya Pan, Han Liu, Yun Wang, Min Li, Liren Liu |
| 143 |
[GO] |
2020―Oct―21 |
Side chain similarity comparisons for integrated drug repositioning and potential toxicity assessments in epidemic response scenarios: the case for COVID-19 |
Nur Syatila Ab Ghani, Reeki Emrizal, Haslina Makmur, Mohd Firdaus-Raih |
| 144 |
[GO] |
2020―Oct―01 |
Structural Insight into the Recognition of S-Adenosyl-L-Homocysteine and Sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA Cap 2’-O-Methyltransferase |
Panupong Mahalapbutr, Napat Kongtaworn, Thanyada Rungrotmongkol |
| 145 |
[GO] |
2020―Sep―24 |
Tailoring Time Series Models For Forecasting Coronavirus Spread: Case Studies of 187 Countries |
Leila Ismail, Huned Materwala, Taieb Znati, Sherzod Turaev, Moien A.B. Khan |
| 146 |
[GO] |
2020―Sep―18 |
An immersive journey to the molecular structure of SARS-CoV-2: Virtual Reality in COVID-19 |
Martín Calvelo, Ángel Piñeiro, Rebeca Garcia-Fandino |
| 147 |
[GO] |
2020―Sep―18 |
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity |
Ratul Chowdhury, Veda Sheersh Boorla, Costas D. Maranas |
| 148 |
[GO] |
2020―Aug―26 |
Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2 |
Qizhang Li, Zhiying Wang, Qiang Zheng, Sen Liu |
| 149 |
[GO] |
2020―Aug―12 |
Structural Insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein |
Abbas Khan, Muhammad Tahir Khan, Shoaib Saleem, Muhammad Junaid, Arif Ali, Syed Shujait Ali, Mazhar Khan, Dong-Qing Wei |
| 150 |
[GO] |
2020―Jul―31 |
Unlocking COVID therapeutic targets: a structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike |
João Trigueiro-Louro, Vanessa Correia, Inês Figueiredo-Nunes, Marta Gíria, Helena Rebelo-de-Andrade |
| 151 |
[GO] |
2020―Jul―17 |
Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses |
Sailen Barik |
| 152 |
[GO] |
2020―Mar―30 |
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model |
Bo Ram Beck, Bonggun Shin, Yoonjung Choi, Sungsoo Park, Keunsoo Kang |
|
